Quantitative high content imaging of cellular adaptive stress response pathways in toxicity for chemical safety assessment
In January 2024, the state opted to pull back that coverage
The sample included both males and females (68% boys), children with major neurological syndromes, severe developmental delay, sensory impairments, or medical conditions were excluded
Patients should contact their healthcare provider if they experience recurrent dizziness or lightheadedness that interferes with daily activities, particularly if symptoms persist beyond the first few weeks of therapy or occur with each dose increase
Wittenstein O, Krause F, Fischer M, Domschikowski J, Nitsche M, Henkenberens C, et al